Table 4.
Variable | EQ-5D index value | EQ-VAS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
N = 254 | Crude OR (95 % CI) | p value# | Adjusted ORa (95 % CI) | p value# adjusted | N = 250 | Crude OR (95 % CI) | p value# | Adjusted ORa (95 % CI) | p value# adjusted | |
Female | 87 | 2.7 (1.3–5.3) | 0.05 | 86 | 1.3 (0.6–2.8) | 0.5 | ||||
Age (continuous variable) | 254 | 1.0 (1.0–1.0) | 0.4 | 250 | 1.0 (1.0–1.1) | 0.03 | 1.0 (1.0–1.0) | 0.5 | ||
Time from diagnosis to examination (continuous variable) | 254 | 1.1 (1.0–1.3) | 0.2 | 250 | 1.0 (0.8–1.1) | 0.7 | ||||
Unemployed | 135 | 2.5 (1.3–4.9) | 0.006 | 2.3 (1.1–4.8) | 0.03 | 135 | 4.2 (2.1–8.4) | <0.001 | 4.3 (2.0–9.0) | <0.001 |
BMI > 30.0 kg/m2 | 76 | 3.1 (1.7–5.7) | <0.001 | 2.3 (1.1–4.2) | 0.005 | 75 | 3.3 (1.8–6.1) | 0.003 | 2.5 (1.3–5.0) | 0.008 |
Current or previous daily smoking | 131 | 1.2 (0.7–2.2) | 0.5 | 127 | 1.2 (0.7–2.2) | |||||
Still on anticoagulation | 74 | 0.8 (0.4–1.5) | 0.4 | 72 | 1.2 (0.6–2.3) | 0.6 | ||||
No ECS after DVT | 21 | 1.1 (0.3–3.4) | 0.9 | 18 | 0.7 (0.2–2.4) | 0.6 | ||||
COPD | 13 | 1.6 (0.5–5.7) | 0.4 | 12 | 1.7 (0.5–6.0) | 0.4 | ||||
Heart failure | 12 | 1.2 (0.3–4.8) | 0.7 | 12 | 3.7 (1.1–11.9) | 0.03 | ||||
Current or previous cancer | 24 | 1.3 (0.5–3.4) | 0.6 | 24 | 2.3 (0.9–5.4) | 0.08 | ||||
Proximal DVTb | 161 | 0.8 (0.4–1.6) | 0.6 | 159 | 0.9 (0.5–1.8) | 0.8 | ||||
PTS | 121 | 13.9 (5.7–34.1) | <0.001 | 11.0 (4.6–29.7) | <0.001 | 120 | 5.9 (2.9–11.9) | <0.001 | 4.8 (2.3–10.0) | <0.001 |
Multiple DVTs | 79 | 1.4 (0.8–2.7) | 0.3 | 71 | 1.4 (0.7–2.6) | 0.3 | ||||
Provoked DVT | 119 | 0.8 (0.4–1.5) | 0.5 | 116 | 1 (0.5–1.7) | 0.9 |
DVT deep vein thrombosis, ECS elastic compression stockings, BMI body mass index, PTS post thrombotic syndrome, COPD chronic pulmonary obstructive disease, Impaired HRQoL EQ-5D index value <25th percentile in patient group (0.72) and EQ VAS value <25th percentile in patient group (60)
#Wald test
aAdjusted for all other significant variables in the multivariate model
bIn or above popliteal vein